Table 1: Demographic Details of the Cohort at Presentation.

 

Participant

No.

Age

Sex

Smoking status

at treatment

Alcohol intake

at treatment

TNM Classification

and Location

Treatment

01

58

M

Never

Current

T1N2b R oropharynx/BOT

Radiotherapy

02

46

M

Never

Current

T3N1 oropharynx/R tonsil

Chemoradiotherapy

03

61

M

Never

Ex

T1N2a oropharynx

Chemoradiotherapy

04

76

M

Ex

-

T3N2c R tonsil

Chemoradiotherapy

05

49

M

Current

Current

T3N2c BOT

Chemoradiotherapy

06

39

M

Never

Current

T3N2c BOT

Chemoradiotherapy

07

49

M

Ex

Current

T3N3 R tonsil/glottis

Chemoradiotherapy

08

59

M

Ex

Current

T3N2c BOT

Chemoradiotherapy

09

66

M

Ex

Current

T3N1 L tonsil

Chemoradiotherapy

10

58

M

Ex

Current

T2N0 glottis

Radiotherapy

11

49

F

Ex

Current

T3N2 R tonsil

Chemoradiotherapy

12

65

M

Current

Current

T1N0 glottis

Radiotherapy

13

61

M

Current

Current

T2N0 glottis

Radiotherapy

14

65

M

Ex

Current

T4N3 L tonsil

Chemoradiotherapy

15

43

M

Ex

Current

T1N2b L tonsil

Chemoradiotherapy

16

54

M

Never

Current

T3N2a R tonsil

Chemoradiotherapy

17

65

M

Current

Current

T3N0 R vocal cord

Chemoradiotherapy

18

51

M

Current

Current

T3N2b L tonsil

Chemoradiotherapy

19

62

F

Current

Current

T3N2 post cricoid region

Chemoradiotherapy

20

62

F

Current

Nil

T2N1 L BOT

Chemoradiotherapy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note. M: Male; F: Female; Ex: Past smoker/drinker; Nil: Never smoke/no alcohol intake; Current: Current smoker/drinker;

L: Left; R: Right; T: Tumour; N: Nodal involvement; BOT: Base of Tongue; - = Information regarding alcohol history not reported.